Translate page

CML is a rare cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. With the average age of diagnosis of CML being around 60 in western countries, CML in children is considered an ultra-rare condition.

Read more about pediatric CML here.


logo_cmladvocates_106The CML Advocates Network is both a virtual network and internet platform for patient organisations supporting patients and relatives affected by Chronic Myeloid Leukaemia (CML). Launched in 2007 with 4 founding member groups, it has now grown to more than 128 leukaemia patient groups in more than 93 countries on all continents, offering support by sharing of best practice, information and advice for CML patient representatives.

Millot EHA 2019 
Professor Fréderic Millot
University of Poitiers, Poitiers (France)

Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.
Latest publications include:

Search here for more publications on pediatric CML

Our 'Clinical Case Discussion Forum' features a number of discussions on pediatric CML cases. If you are a physician treating pediatric CML patients, please join our forum and get in touch with other experts.

The latest postings on pediatric CML include:

A number of clinical trials and research activities are currently ongoing to research pediatric CML.
Find more information here.